Zanamivir for the Treatment of Clinically Diagnosed Influenza in Clinical PracticeResults of the Valuable-Insights-from-Patients Study

被引：0
|
作者：
Richard Johnson
Jo Ellen Schweinle
Scott Burroughs
机构：
[1] Quintiles,
[2] Glaxo Wellcome,undefined
[3] Inc.,undefined
来源：
Clinical Drug Investigation | 2000年 / 20卷
关键词：
Influenza; Normal Activity; Control Clinical Trial; Zanamivir; Clinician Office;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Background: The efficacy and tolerability of the neuraminidase inhibitor zanamivir in the treatment of influenza have been established in an extensive programme of controlled clinical trials.
引用
收藏
页码：327 / 336
页数：9
相关论文
共 50 条
  • [1] Zanamivir for the treatment of clinically diagnosed influenza in clinical practice - Results of the valuable-insights-from-patients study
    Johnson, R
    Schweinle, JE
    Burroughs, S
    CLINICAL DRUG INVESTIGATION, 2000, 20 (05) : 327 - 336
  • [2] Virus Susceptibility Analyses from a Phase IV Clinical Trial of Inhaled Zanamivir Treatment in Children Infected with Influenza
    Yates, Phillip J.
    Mehta, Nalini
    Horton, Joseph
    Tisdale, Margaret
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2013, 57 (04) : 1677 - 1684
  • [3] Clinical course of patients diagnosed with severe aortic stenosis in the Rotterdam area: insights from the AVARIJN study
    Heuvelman, H. J.
    van Geldorp, M. W. A.
    Kappetein, A. P.
    Geleijnse, M. L.
    Galema, T. W.
    Bogers, A. J. J. C.
    Takkenberg, J. J. M.
    NETHERLANDS HEART JOURNAL, 2012, 20 (12) : 487 - 493
  • [4] Clinical course of patients diagnosed with severe aortic stenosis in the Rotterdam area: insights from the AVARIJN study
    H. J. Heuvelman
    M. W. A. van Geldorp
    A. P. Kappetein
    M. L. Geleijnse
    T. W. Galema
    A. J. J. C. Bogers
    J. J. M. Takkenberg
    Netherlands Heart Journal, 2012, 20 : 487 - 493
  • [5] Clinical Efficacy of Inhaled Zanamivir for the Treatment of Patients with Influenza B Virus InfectionA Pooled Analysis of Randomised, Placebo-Controlled Studies
    Albert D. M. E. Osterhaus
    James A. Hedrick
    Kelly J. Henrickson
    Mika J. Mäkelä
    Alison Webster
    Oliver N. Keene
    Clinical Drug Investigation, 2000, 20 : 223 - 228
  • [6] Clinical efficacy of inhaled zanamivir for the treatment of patients with influenza B virus infection -: A pooled analysis of randomised, placebo-controlled studies
    Osterhaus, ADME
    Hedrick, JA
    Henrickson, KJ
    Mäkelä, MJ
    Webster, A
    Keene, ON
    CLINICAL DRUG INVESTIGATION, 2000, 20 (04) : 223 - 228
  • [7] Analysis of clinical characteristics of 213 clinically diagnosed pediatric patients with paragonimiasis from Yunnan, China
    Huang, Yi
    Yang, Xiaotao
    Zhu, Ying
    Bai, Houxi
    Jiao, Feng
    Jin, Haifeng
    Chen, Houyu
    Guo, Yan
    Cui, Penghao
    Wang, Yanchun
    Luo, Yonghan
    BMC INFECTIOUS DISEASES, 2025, 25 (01)
  • [8] Evaluation of safety and efficacy of intravenous zanamivir in the treatment of hospitalized Japanese patients with influenza: an open-label, single-arm study
    Watanabe, Akira
    Yates, Phillip J.
    Murayama, Marie
    Soutome, Toru
    Furukawa, Hiroiku
    ANTIVIRAL THERAPY, 2015, 20 (04) : 415 - 423
  • [9] Pharmacogenetic markers and macrolide safety in influenza patients: insights from a prospective study
    Skryabina, A. A.
    Nikiforov, V. V.
    Shakhmardanov, M. Z.
    Zastrozhin, M. S.
    Sychev, D. A.
    PHARMACOGENOMICS, 2024, 25 (16-18) : 661 - 665
  • [10] Clinical efficacy and safety of the orally inhaled neuraminidase inhibitor zanamivir in the treatment of influenza:: a randomized, double-blind, placebo-controlled European study
    Mäkelä, MJ
    Pauksens, K
    Rostila, T
    Fleming, DM
    Man, CY
    Keene, ON
    Webster, A
    JOURNAL OF INFECTION, 2000, 40 (01) : 42 - 48
12345